Anika Therapeutics, Inc. (ANIK)
19.10
-0.26
(-1.34%)
USD |
NASDAQ |
Oct 02, 16:00
19.12
+0.02
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Price to Book Value : 1.862 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.862 |
| October 01, 2026 | 1.887 |
| September 30, 2026 | 1.917 |
| September 29, 2026 | 1.944 |
| September 28, 2026 | 2.016 |
| September 25, 2026 | 1.986 |
| September 24, 2026 | 1.972 |
| September 23, 2026 | 1.986 |
| September 22, 2026 | 2.036 |
| September 21, 2026 | 2.018 |
| September 18, 2026 | 2.029 |
| September 17, 2026 | 2.050 |
| September 16, 2026 | 2.032 |
| September 15, 2026 | 2.038 |
| September 14, 2026 | 2.066 |
| September 11, 2026 | 2.034 |
| September 10, 2026 | 2.046 |
| September 09, 2026 | 2.036 |
| September 08, 2026 | 2.051 |
| September 04, 2026 | 2.029 |
| September 03, 2026 | 2.047 |
| September 02, 2026 | 2.101 |
| September 01, 2026 | 2.058 |
| August 31, 2026 | 2.034 |
| August 28, 2026 | 2.057 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.032 |
| August 26, 2026 | 2.114 |
| August 25, 2026 | 2.086 |
| August 24, 2026 | 2.080 |
| August 21, 2026 | 2.123 |
| August 20, 2026 | 2.080 |
| August 19, 2026 | 2.072 |
| August 18, 2026 | 2.103 |
| August 17, 2026 | 2.093 |
| August 14, 2026 | 2.096 |
| August 13, 2026 | 2.064 |
| August 12, 2026 | 2.148 |
| August 11, 2026 | 2.070 |
| August 10, 2026 | 2.016 |
| August 07, 2026 | 2.088 |
| August 06, 2026 | 1.965 |
| August 05, 2026 | 1.871 |
| August 04, 2026 | 1.912 |
| August 03, 2026 | 2.021 |
| July 31, 2026 | 1.880 |
| July 30, 2026 | 1.762 |
| July 29, 2026 | 1.576 |
| July 28, 2026 | 1.477 |
| July 27, 2026 | 1.464 |
| July 24, 2026 | 1.457 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Precigen, Inc. | 70.16 |
| Repligen Corp. | 4.854 |
| Amgen, Inc. | 18.64 |
| Biogen, Inc. | 1.723 |
| BioMarin Pharmaceutical, Inc. | 1.750 |
Price to Book Value Related Metrics
| PS Ratio | 2.230 |
| Price to Free Cash Flow | 478.66 |
| Price | 19.10 |
| Earnings Yield | -1.44% |
| Market Cap | 255.62M |